Magyar szkizofrénia-biobank a szkizofréniakutatás és a személyre szabott orvoslás szolgálatában

Translated title of the contribution: SCHIZOBANK - The Hungarian national schizophrenia biobank and its role in schizophrenia research

Gabriella Inczédy-Farkas, Judit Benkovits, Nóra Balogh, Péter Álmos, B. Scholtz, Gábor Zahuczky, Zsolt Török, Krisztián Nagy, J. Réthelyi, Zoltán Makkos, Ákos Kassai-Farkas, Anikó Igerházy, Judit Tuzko, Z. Janka, I. Bitter, György Németh, L. Nagy, Mária Judit Molnár

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Delineating the pathogenesis of multifactorial diseases is a major challenge of the postgenomial era. Genetic factors are known to play an important role in the pathogenesis of certain psychiatric disorders as well as in the development of adverse reactions to psychoactive drugs. Containing large numbers of samples and linking them clinical data, biobanks are gaining importance in the studies of chronic multifactorial diseases. Several biobanks are under establishment in Hungary. The first initiative to collect samples in neurological and psychiatric disorders was the NEPSYBANK coordinated by the Hungarian Society of Clinical Neurogenetics. The national biobank network is currently established by the NEKIFUT project of the National Office of Research and Technology. In this article we describe the structure, logistics and informatical background of the national schizophrenia biobank (SCHIZOBANK). The initiative of the SCHIZOBANK originates from a consortium in which academy and health industry partners are collecting biological materials and data in five major psychiatric center under the coordination of the Medical and Health Science Center of the University of Debrecen. We review other international schizophrenia biobanks as well. Major strength of the SCHIZOBANK is the collection of very detailed phenotypic data and of RNA and plasma both in psychotic and non-psychotic state of the patient which permits longitudinal follow-up and the study of both static and dynamically changing transcriptomic, proteomic and metabolomic markers. The collection of the SCHIZOBANK is available not only to consortial partners but to other national and international research groups as well.

Original languageHungarian
Pages (from-to)1403-1408
Number of pages6
JournalOrvosi Hetilap
Volume151
Issue number35
DOIs
Publication statusPublished - Aug 1 2010

Fingerprint

Schizophrenia
Psychiatry
Research
Metabolomics
Hungary
Psychotropic Drugs
Health
Nervous System Diseases
Proteomics
Industry
Chronic Disease
RNA
Technology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Inczédy-Farkas, G., Benkovits, J., Balogh, N., Álmos, P., Scholtz, B., Zahuczky, G., ... Molnár, M. J. (2010). Magyar szkizofrénia-biobank a szkizofréniakutatás és a személyre szabott orvoslás szolgálatában. Orvosi Hetilap, 151(35), 1403-1408. https://doi.org/10.1556/OH.2010.28943

Magyar szkizofrénia-biobank a szkizofréniakutatás és a személyre szabott orvoslás szolgálatában. / Inczédy-Farkas, Gabriella; Benkovits, Judit; Balogh, Nóra; Álmos, Péter; Scholtz, B.; Zahuczky, Gábor; Török, Zsolt; Nagy, Krisztián; Réthelyi, J.; Makkos, Zoltán; Kassai-Farkas, Ákos; Igerházy, Anikó; Tuzko, Judit; Janka, Z.; Bitter, I.; Németh, György; Nagy, L.; Molnár, Mária Judit.

In: Orvosi Hetilap, Vol. 151, No. 35, 01.08.2010, p. 1403-1408.

Research output: Contribution to journalArticle

Inczédy-Farkas, G, Benkovits, J, Balogh, N, Álmos, P, Scholtz, B, Zahuczky, G, Török, Z, Nagy, K, Réthelyi, J, Makkos, Z, Kassai-Farkas, Á, Igerházy, A, Tuzko, J, Janka, Z, Bitter, I, Németh, G, Nagy, L & Molnár, MJ 2010, 'Magyar szkizofrénia-biobank a szkizofréniakutatás és a személyre szabott orvoslás szolgálatában', Orvosi Hetilap, vol. 151, no. 35, pp. 1403-1408. https://doi.org/10.1556/OH.2010.28943
Inczédy-Farkas, Gabriella ; Benkovits, Judit ; Balogh, Nóra ; Álmos, Péter ; Scholtz, B. ; Zahuczky, Gábor ; Török, Zsolt ; Nagy, Krisztián ; Réthelyi, J. ; Makkos, Zoltán ; Kassai-Farkas, Ákos ; Igerházy, Anikó ; Tuzko, Judit ; Janka, Z. ; Bitter, I. ; Németh, György ; Nagy, L. ; Molnár, Mária Judit. / Magyar szkizofrénia-biobank a szkizofréniakutatás és a személyre szabott orvoslás szolgálatában. In: Orvosi Hetilap. 2010 ; Vol. 151, No. 35. pp. 1403-1408.
@article{bb67ba47790b46b894b44ef4b39d6793,
title = "Magyar szkizofr{\'e}nia-biobank a szkizofr{\'e}niakutat{\'a}s {\'e}s a szem{\'e}lyre szabott orvosl{\'a}s szolg{\'a}lat{\'a}ban",
abstract = "Delineating the pathogenesis of multifactorial diseases is a major challenge of the postgenomial era. Genetic factors are known to play an important role in the pathogenesis of certain psychiatric disorders as well as in the development of adverse reactions to psychoactive drugs. Containing large numbers of samples and linking them clinical data, biobanks are gaining importance in the studies of chronic multifactorial diseases. Several biobanks are under establishment in Hungary. The first initiative to collect samples in neurological and psychiatric disorders was the NEPSYBANK coordinated by the Hungarian Society of Clinical Neurogenetics. The national biobank network is currently established by the NEKIFUT project of the National Office of Research and Technology. In this article we describe the structure, logistics and informatical background of the national schizophrenia biobank (SCHIZOBANK). The initiative of the SCHIZOBANK originates from a consortium in which academy and health industry partners are collecting biological materials and data in five major psychiatric center under the coordination of the Medical and Health Science Center of the University of Debrecen. We review other international schizophrenia biobanks as well. Major strength of the SCHIZOBANK is the collection of very detailed phenotypic data and of RNA and plasma both in psychotic and non-psychotic state of the patient which permits longitudinal follow-up and the study of both static and dynamically changing transcriptomic, proteomic and metabolomic markers. The collection of the SCHIZOBANK is available not only to consortial partners but to other national and international research groups as well.",
keywords = "biobanking, database, personalized medicine, schizophrenia",
author = "Gabriella Incz{\'e}dy-Farkas and Judit Benkovits and N{\'o}ra Balogh and P{\'e}ter {\'A}lmos and B. Scholtz and G{\'a}bor Zahuczky and Zsolt T{\"o}r{\"o}k and Kriszti{\'a}n Nagy and J. R{\'e}thelyi and Zolt{\'a}n Makkos and {\'A}kos Kassai-Farkas and Anik{\'o} Igerh{\'a}zy and Judit Tuzko and Z. Janka and I. Bitter and Gy{\"o}rgy N{\'e}meth and L. Nagy and Moln{\'a}r, {M{\'a}ria Judit}",
year = "2010",
month = "8",
day = "1",
doi = "10.1556/OH.2010.28943",
language = "Hungarian",
volume = "151",
pages = "1403--1408",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "35",

}

TY - JOUR

T1 - Magyar szkizofrénia-biobank a szkizofréniakutatás és a személyre szabott orvoslás szolgálatában

AU - Inczédy-Farkas, Gabriella

AU - Benkovits, Judit

AU - Balogh, Nóra

AU - Álmos, Péter

AU - Scholtz, B.

AU - Zahuczky, Gábor

AU - Török, Zsolt

AU - Nagy, Krisztián

AU - Réthelyi, J.

AU - Makkos, Zoltán

AU - Kassai-Farkas, Ákos

AU - Igerházy, Anikó

AU - Tuzko, Judit

AU - Janka, Z.

AU - Bitter, I.

AU - Németh, György

AU - Nagy, L.

AU - Molnár, Mária Judit

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Delineating the pathogenesis of multifactorial diseases is a major challenge of the postgenomial era. Genetic factors are known to play an important role in the pathogenesis of certain psychiatric disorders as well as in the development of adverse reactions to psychoactive drugs. Containing large numbers of samples and linking them clinical data, biobanks are gaining importance in the studies of chronic multifactorial diseases. Several biobanks are under establishment in Hungary. The first initiative to collect samples in neurological and psychiatric disorders was the NEPSYBANK coordinated by the Hungarian Society of Clinical Neurogenetics. The national biobank network is currently established by the NEKIFUT project of the National Office of Research and Technology. In this article we describe the structure, logistics and informatical background of the national schizophrenia biobank (SCHIZOBANK). The initiative of the SCHIZOBANK originates from a consortium in which academy and health industry partners are collecting biological materials and data in five major psychiatric center under the coordination of the Medical and Health Science Center of the University of Debrecen. We review other international schizophrenia biobanks as well. Major strength of the SCHIZOBANK is the collection of very detailed phenotypic data and of RNA and plasma both in psychotic and non-psychotic state of the patient which permits longitudinal follow-up and the study of both static and dynamically changing transcriptomic, proteomic and metabolomic markers. The collection of the SCHIZOBANK is available not only to consortial partners but to other national and international research groups as well.

AB - Delineating the pathogenesis of multifactorial diseases is a major challenge of the postgenomial era. Genetic factors are known to play an important role in the pathogenesis of certain psychiatric disorders as well as in the development of adverse reactions to psychoactive drugs. Containing large numbers of samples and linking them clinical data, biobanks are gaining importance in the studies of chronic multifactorial diseases. Several biobanks are under establishment in Hungary. The first initiative to collect samples in neurological and psychiatric disorders was the NEPSYBANK coordinated by the Hungarian Society of Clinical Neurogenetics. The national biobank network is currently established by the NEKIFUT project of the National Office of Research and Technology. In this article we describe the structure, logistics and informatical background of the national schizophrenia biobank (SCHIZOBANK). The initiative of the SCHIZOBANK originates from a consortium in which academy and health industry partners are collecting biological materials and data in five major psychiatric center under the coordination of the Medical and Health Science Center of the University of Debrecen. We review other international schizophrenia biobanks as well. Major strength of the SCHIZOBANK is the collection of very detailed phenotypic data and of RNA and plasma both in psychotic and non-psychotic state of the patient which permits longitudinal follow-up and the study of both static and dynamically changing transcriptomic, proteomic and metabolomic markers. The collection of the SCHIZOBANK is available not only to consortial partners but to other national and international research groups as well.

KW - biobanking

KW - database

KW - personalized medicine

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=77956333505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956333505&partnerID=8YFLogxK

U2 - 10.1556/OH.2010.28943

DO - 10.1556/OH.2010.28943

M3 - Article

VL - 151

SP - 1403

EP - 1408

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 35

ER -